A detailed history of Whittier Trust CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Whittier Trust CO holds 1,533 shares of VRTX stock, worth $792,162. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,533
Previous 1,447 5.94%
Holding current value
$792,162
Previous $678,000 5.01%
% of portfolio
0.01%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$460.0 - $505.78 $39,560 - $43,497
86 Added 5.94%
1,533 $712,000
Q2 2024

Jul 26, 2024

BUY
$392.81 - $485.53 $47,922 - $59,234
122 Added 9.21%
1,447 $678,000
Q1 2024

May 02, 2024

BUY
$407.69 - $446.08 $26,499 - $28,995
65 Added 5.16%
1,325 $553,000
Q4 2023

Jan 11, 2024

BUY
$343.0 - $410.68 $125,195 - $149,898
365 Added 40.78%
1,260 $512,000
Q3 2023

Oct 27, 2023

SELL
$338.18 - $362.46 $15,556 - $16,673
-46 Reduced 4.89%
895 $311,000
Q2 2023

Jul 24, 2023

SELL
$314.42 - $351.91 $3,458 - $3,871
-11 Reduced 1.16%
941 $331,000
Q4 2022

Jan 25, 2023

SELL
$285.76 - $321.48 $47,721 - $53,687
-167 Reduced 14.92%
952 $0
Q3 2022

Oct 21, 2022

SELL
$273.83 - $305.53 $5,476 - $6,110
-20 Reduced 1.76%
1,119 $324,000
Q2 2022

Jul 28, 2022

SELL
$234.96 - $292.55 $3,289 - $4,095
-14 Reduced 1.21%
1,139 $321,000
Q1 2022

Apr 29, 2022

BUY
$221.42 - $260.97 $1,992 - $2,348
9 Added 0.79%
1,153 $301,000
Q4 2021

Jan 19, 2022

BUY
$177.01 - $223.45 $39,650 - $50,052
224 Added 24.35%
1,144 $251,000
Q3 2021

Nov 01, 2021

SELL
$181.39 - $202.99 $7,255 - $8,119
-40 Reduced 4.17%
920 $167,000
Q2 2021

Jul 29, 2021

SELL
$187.49 - $221.1 $13,124 - $15,477
-70 Reduced 6.8%
960 $194,000
Q1 2021

Apr 26, 2021

BUY
$207.02 - $241.31 $1,035 - $1,206
5 Added 0.49%
1,030 $221,000
Q4 2020

Jan 29, 2021

SELL
$207.01 - $276.09 $23,599 - $31,474
-114 Reduced 10.01%
1,025 $242,000
Q3 2020

Oct 30, 2020

BUY
$255.65 - $303.1 $5,624 - $6,668
22 Added 1.97%
1,139 $310,000
Q2 2020

Jul 10, 2020

BUY
$225.48 - $295.8 $31,341 - $41,116
139 Added 14.21%
1,117 $324,000
Q1 2020

Apr 27, 2020

BUY
$199.77 - $247.81 $2,597 - $3,221
13 Added 1.35%
978 $232,000
Q4 2019

Jan 31, 2020

SELL
$166.71 - $223.91 $2,167 - $2,910
-13 Reduced 1.33%
965 $211,000
Q3 2019

Oct 18, 2019

BUY
$166.23 - $187.09 $20,612 - $23,199
124 Added 14.52%
978 $166,000
Q2 2018

Jul 27, 2018

BUY
$145.72 - $169.96 $63,242 - $73,762
434 Added 103.33%
854 $145,000
Q2 2018

Jul 20, 2018

SELL
$145.72 - $169.96 $83,206 - $97,047
-571 Reduced 57.62%
420 $40,000
Q4 2017

Feb 07, 2018

BUY
$137.28 - $155.55 $82,368 - $93,330
600 Added 153.45%
991 $149,000
Q3 2017

Oct 23, 2017

BUY
$148.13 - $162.24 $57,918 - $63,435
391
391 $59,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $133B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Whittier Trust CO Portfolio

Follow Whittier Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO with notifications on news.